
Nutrigenomics and personalized nutrition are touted as the future of nutrition, but where do we stand today? In this five part special on nutrigenomics NutraIngredients-USA looks back on the brief history of nutrigenomics, examines Nestlé's epigenetics interests, uncovers the potential 'goldmine' of data, and asks 'where next for nutrigenomics and personalized nutrition?'
At the recent IFT Annual Meeting and Expo, Stephen Daniells talked to Dr Jim Kaput, director of FDA’s Division of Personalized Nutrition and Medicine about the paradigm shift needed to move personalized nutrition forward.
Understanding and achieving nutrition’s potential to maintain health and prevent disease may lie with the study of epigenetics, according to a new review.
In the second part of our special on Nutrigenomics, we take a look at the progress to date, from the first reports of DNA to predictions of nutrigenomic foods filling supermarket shelves (everyone says they're 5-10 years away...).
Understanding the fine details of physiology, rather than looking at surrogate biomarkers of health and disease, can open up new doorways and a ‘goldmine’ of information on how the diet affects our health, according to a leading nutrigenomics expert.
In the fourth part of our nutrigenomics special edition NutraIngredients takes a look at how the field could help to deliver a more personal approach to nutrition in the future.
The benefits of nutrigenomics tools to illuminate the effect of certain nutrients on genes are occurring right now, but talk of personalized nutrition should be left for the future, says a DSM corporate scientist.